| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.099 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |